Literature DB >> 12615254

Pseudonormalized Doppler total ejection isovolume (Tei) index in patients with right ventricular acute myocardial infarction.

Shiro Yoshifuku1, Yutaka Otsuji, Kunitsugu Takasaki, Keiko Yuge, Akira Kisanuki, Koichi Toyonaga, Souki Lee, Takashi Murayama, Hitoshi Nakashima, Toshiro Kumanohoso, Shinichi Minagoe, Chuwa Tei.   

Abstract

The Doppler total ejection isovolume (Tei) index is useful for estimating global cardiac function. However, the relation between the right ventricular (RV) Tei index and RV infarction has not been investigated. The relation between the RV Tei index and severity of RV infarction was evaluated in 25 patients with inferior wall acute myocardial infarction (13 with and 12 without RV infarction). RV infarction was diagnosed when right atrial pressure was > or = 10 mm Hg or when right atrial pressure/pulmonary capillary wedge pressure was >0.8 by catheterization. The RV Tei index was significantly increased in patients with RV infarction compared with those without (0.53 +/- 0.15 vs 0.38 +/- 0.14, p <0.05). The RV Tei index in patients with severe RV infarction (right atrial pressure > or = 15 mm Hg) was significantly smaller compared with those with mild/moderate RV infarction (right atrial pressure <15 mm Hg) and showed no significant difference in patients with myocardial infarction but without RV infarction (0.44 +/- 0.09 vs 0.61 +/- 0.16 vs 0.38 +/- 0.14, severe RV infarction vs mild/moderate RV infarction vs no RV infarction, p <0.01). The RV Tei index is generally increased in patients with RV infarction; however, severe RV infarction can be manifested with limited or no increase in the Tei index (pseudonormalization).

Entities:  

Mesh:

Year:  2003        PMID: 12615254     DOI: 10.1016/s0002-9149(02)03299-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Right ventricular failure: a novel era of targeted therapy.

Authors:  Dipanjan Banerjee; Francois Haddad; Roham T Zamanian; Jayan Nagendran
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 2.  Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography.

Authors:  Antonio Vitarelli; Claudio Terzano
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

3.  Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?

Authors:  Katsu Takenaka
Journal:  J Echocardiogr       Date:  2018-10-05

4.  Myocardial Function during Ventilation with Lower versus Higher Positive End-Expiratory Pressure in Patients without ARDS.

Authors:  Anna Geke Algera; Charalampos Pierrakos; Michela Botta; Claudio Zimatore; Luigi Pisani; Pieter-Roel Tuinman; Lieuwe D J Bos; Wim K Lagrand; Marcello Gama de Abreu; Paolo Pelosi; Ary Serpa Neto; Marcus J Schultz; Thomas G V Cherpanath; Frederique Paulus
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

5.  Impact of right ventricular diastolic dysfunction on clinical outcomes in inferior STEMI.

Authors:  B Altıntaş; B Yaylak; H Ede; R Altındağ; E Baysal; Ö Bilge; H Çiftçi; M Ş Adıyaman; M Z Karahan; I Kaya; K Çevik
Journal:  Herz       Date:  2017-10-09       Impact factor: 1.443

6.  Right ventricular myocardial performance index is decreased with severe pressure-overload cardiac hypertrophy in young rats.

Authors:  Jeong-Hyeon Ko; Gwang Hyeon Eom; Hwa Jin Cho; Kwang-Il Nam; Jae Sook Ma; Hyun Kook; Young Kuk Cho
Journal:  Pediatr Cardiol       Date:  2013-03-07       Impact factor: 1.655

Review 7.  Strain Imaging for the Early Detection of Cardiac Remodeling and Dysfunction in Primary Aldosteronism.

Authors:  Yilin Chen; Tingyan Xu; Jianzhong Xu; Limin Zhu; Dian Wang; Yan Li; Jiguang Wang
Journal:  Diagnostics (Basel)       Date:  2022-02-20

8.  A novel index equivalent to the myocardial performance index for right ventricular functional assessment in children and adolescent patients.

Authors:  Yasunobu Hayabuchi; Yukako Homma; Shoji Kagami
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.